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Diffusion histology imaging 
differentiates distinct pediatric 
brain tumor histology
Zezhong Ye1,8, Komal Srinivasa2,8, Ashely Meyer3, Peng Sun1, Joshua Lin1,6, 
Jeffrey D. Viox1,7, Chunyu Song4, Anthony T. Wu4, Sheng‑Kwei Song1,4*, Sonika Dahiya2* & 
Joshua B. Rubin3,5*
High‑grade pediatric brain tumors exhibit the highest cancer mortality rates in children. While 
conventional MRI has been widely adopted for examining pediatric high‑grade brain tumors clinically, 
accurate neuroimaging detection and differentiation of tumor histopathology for improved diagnosis, 
surgical planning, and treatment evaluation, remains an unmet need in their clinical management. 
We employed a novel Diffusion Histology Imaging (DHI) approach employing diffusion basis spectrum 
imaging (DBSI) derived metrics as the input classifiers for deep neural network analysis. DHI aims to 
detect, differentiate, and quantify heterogeneous areas in pediatric high‑grade brain tumors, which 
include normal white matter (WM), densely cellular tumor, less densely cellular tumor, infiltrating 
edge, necrosis, and hemorrhage. Distinct diffusion metric combination would thus indicate the 
unique distributions of each distinct tumor histology features. DHI, by incorporating DBSI metrics and 
the deep neural network algorithm, classified pediatric tumor histology with an overall accuracy of 
85.8%. Receiver operating analysis (ROC) analysis suggested DHI’s great capability in distinguishing 
individual tumor histology with AUC values (95% CI) of 0.984 (0.982–0.986), 0.960 (0.956–0.963), 
0.991 (0.990–0.993), 0.950 (0.944–0.956), 0.977 (0.973–0.981) and 0.976 (0.972–0.979) for normal 
WM, densely cellular tumor, less densely cellular tumor, infiltrating edge, necrosis and hemorrhage, 
respectively. Our results suggest that DBSI‑DNN, or DHI, accurately characterized and classified 
multiple tumor histologic features in pediatric high‑grade brain tumors. If these results could be 
further validated in patients, the novel DHI might emerge as a favorable alternative to the current 
neuroimaging techniques to better guide biopsy and resection as well as monitor therapeutic response 
in patients with high‑grade brain tumors.
Pediatric brain tumors are the second most common childhood malignancy and the most common solid tumor 
in  children1. Pediatric brain cancer has unfortunately surpassed leukemia to become the most common cause 
of childhood cancer death in the  US2. It is estimated that 2940 new cases of childhood (0–14 age group) and 
adolescent (15–19 age group) primary malignant and non-malignant central nervous system (CNS) tumors will 
be diagnosed in the United States in  20203.
In the past two decades, the advent of neuroimaging technologies has enabled clinicians to detect tumor recur-
rence or dissemination with improved  certainty4. However, these discoveries were developed largely for adult 
brain tumor patients, which are most often biologically distinct from those that occur in children, which exhibit 
unique genomic and imaging  characteristics5. Evaluating pediatric brain tumors is often a diagnostic challenge 
due to their diverse tumor pathologies, nonspecific or overlapping imaging findings, susceptibility artifacts from 
intratumoral calcification or hemorrhage, and motion artifacts in young  children6. Conventional MRI-based 
diagnoses also fail to offer adequate information regarding the specific tumor type, tumor grade, tumor viability, 
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and treatment response of lesions. Although advanced MRI techniques like diffusion tensor imaging (DTI), per-
fusion MRI, MR spectroscopy (MRS), and susceptibility-weighted imaging (SWI) are incorporated into clinical 
MRI protocols, they still fall  short6–8. The widely used multiparametric magnetic resonance imaging (mpMRI) 
approach fails to accurately reflect tumor histopathology such as tumor cellular density, necrosis, hemorrhage, 
or infiltrative edges. As prior studies documented the histological and radiological tumor heterogeneity coex-
isting within high grade tumor lesions, it is imperative to develop a technique capable of discerning the varied 
appearance of these lesions non-invasively9.
We have previously developed diffusion basis spectrum imaging (DBSI)10 demonstrating its ability to quan-
titatively characterize pathologies in multiple central nervous system diseases, including, multiple  sclerosis11–14, 
spinal cord  injury15, and  epilepsy16. More recently, we developed a novel diffusion histology imaging (DHI) 
approach that incorporates DBSI-derived diffusion metrics as the input for a deep neural network (DNN) algo-
rithm to detect and differentiate underlying pathologies in pediatric high-grade brain tumors.
Materials and methods
Study design. This study has been approved by the institutional review board of Washington University 
School of Medicine. Informed consent was obtained from all subjects’ parents and/or legal guardians for the use 
of samples in this study. All methods were carried out in accordance with relevant guidelines and regulations. 
Nine post-mortem pediatric brain tumor specimens that were part of the Washington University Legacy Project 
were included for the study. Among these nine pediatric patients, four were male and five were female.
Postmortem brain specimen. The autopsy was performed within 24 h of the death of the patients to pre-
vent the deterioration of the tissue. The brain specimen was immediately fixed in formalin right after the autopsy 
(Fig. 1b). The tissue blocks were obtained from the brain specimen no sooner than seven days after the formalin 
fixation (Fig. 1c). A total of 45 samples were resected from tumor, tumor interface with normal adjacent brain, 
areas of hemorrhage and necrosis, as well as normal brain tissue (Fig. 1c). The average size of the specimens was 
21 mm ± 4 mm.
Ex vivo MRI of brain specimen. Brain tumor specimens were submersed in formalin for ex vivo imaging 
to keep tissue from dehydration during study. The specimens were examined using a 4.7-T Agilent/Varian MR 
scanner (Agilent Technologies, Santa Clara, CA) and a custom-built circular surface coil (3.5-cm diameter). 
A multi-echo spin-echo diffusion weighted sequence using 99 diffusion-encoding directions with maximum 
b-values = 3000 s/mm2 was employed to acquire diffusion-weighted images. The imaging parameters were as 
follows: repetition time (TR) = 1500 ms, echo time (TE) = 40 ms, time between application of gradient pulse 
20 ms, diffusion gradient on time 8 ms, slice thickness 0.5 mm, field-of-view (FOV) 32 × 32  mm2, data matrix 
128 × 128, number of average 1, in-plane resolution 0.25 × 0.25  mm2. T2W images were acquired with a multi-
slice spin echo sequence with TR = 4000 ms, echo time TE = 80 ms, FOV 32 × 32  mm2, data matrix 128 × 128. 
T1W images were acquired with a gradient echo sequence with TR = 80 ms, TE = 10 ms, FOV 32 × 32  mm2, data 
matrix 128 × 128, 8 averages.
DBSI analysis of brain tumor. DBSI models brain tumor diffusion-weighted MRI signals as a linear com-
bination of discrete multiple anisotropic diffusion tensors and a spectrum of isotropic diffusion tensors:
In1, bk is the kth diffusion gradient; Sk/S0 is the acquired diffusion-weighted signal at direction of bk normal-
ized to non-diffusion-weighted signal; NAniso is number of anisotropic tensors to be determined; ϕik is the angle 









 is b-value of the kth 
diffusion gradient; λ||i and λ⟂i are axial and radial diffusivity of the ith anisotropic tensor under the assumption 
of cylindrical symmetry; fi is signal-intensity-fraction of the ith anisotropic tensor; a, b are low and high diffusiv-
ity limits of isotropic diffusion spectrum; f(D) is signal-intensity-fraction at isotropic diffusivity D.
Based on our ex vivo MRI and histological analyses of resected specimens from previous  studies17, the 
following isotropic-diffusion profiles were established. We observed that highly restricted isotropic diffusion 
(0 ≤ D ≤ 0.2 μm2/ms) is associated with lymphocytes; restricted-isotropic diffusion (0.2 < D ≤ 0.8 μm2/ms) is 
associated with dense tumor cellularity; and hindered-isotropic diffusion (0.8 < D ≤ 2 µm2/ms) is associated 
with tumor necrosis. DBSI provides a simple tensor expression for individual image voxels to visualize morpho-
logical features secondary to tumor formation, some of which are not as discretely detectable by conventional 
MRI. It is the sensitivity of diffusion-weighted MRI signal to the microstructural changes that allows DBSI to 
more precisely reflect morphological changes resulting from tumor presence or other pathologic alterations. 
By using this feature of DBSI as the input for deep neural network algorithms, we created DHI to recapitulate 
histopathologic analysis using MRI.
Histologic staining and evaluation. The formalin-fixed tissue was embedded in paraffin after scanning. 
The paraffin embedded tissue was then sequentially sectioned at 5-μm thickness and stained with hematoxylin 
and eosin (H&E). Histology slides were digitized using NanoZoomer 2.0-HT System (Hamamatsu, Japan) with 
a 20 × objectives for analyses. Two experienced neuropathologists (K.S. and S.D.) reviewed all the histological 
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densely cellular tumor (DC tumor), less densely cellular tumor (LDC tumor), necrosis, tumor infiltrative edge, 
and hemorrhage were outlined and drawn on H&E images with 20× magnification.
Image processing. Voxel-wise DTI and DBSI analyses were performed by an in-house software developed 
using MATLAB® (MathWorks; Natick, MA). The computation time for DTI and DBSI for each specimen is about 
40 min.
Co‑registration between histology images and ex vivo MRI. The two dimensional (2D) thin plate 
spline (TPS) registration was performed using MIPAV (Version 10.0.0, NIH; https ://mipav .cit.nih.gov/index 
.php) as described in our previous  study17 to co-register the histology images with MR images. To achieve suc-
cessful co-registration, we first ensured the plane of histology section of the brain tumor specimens matched 
closely with the slice plane of the corresponding T2-weighted (T2W) images. For the co-registration preprocess-
ing, the RGB format of H&E images with histology annotations were converted to grayscale format to match 
with T2W images (Fig. 2) using the Pillow package in Python 3.6.8 (https ://pillo w.readt hedoc s.io/en/3.1.x/index 
.html#). Afterwards, eighteen pairs of landmarks along the perimeter of each specimen were manually placed 
on both H&E images and T2W images (inherently co-registered with DTI and DBSI maps) to compute the 
transformation matrix for matching H&E images with MRI (Fig. 2). Through successful image co-registration, 
Figure 1.  Illustration of brain specimen procurement from a patient with high-grade pediatric brain tumor. 
(a) In vivo Gd-enhanced T1-weighted image indicated a large lesion (square) with heterogeneous intensities 
in the right posterior region from a 16-year-old patient with embryonal neoplasm (WHO Grade IV). (b) Brain 
specimen was procured and immediately formalin-fixed. (c) Coronal slices revealed a large tumor with admixed 
hemorrhage and necrosis in the right thalamus (arrow). (d) Five tissue blocks were prepared in total i.e. from 
tumor (block 2, blcok 4), tumor interface with normal adjacent brain (block 3), hemorrhage and necrosis (block 
5), as well as grossly normal brain (block 1) (c).
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Figure 2.  Co-registration between histology and MRI. Raw RGB H&E images were first converted to grayscale 
images for enhanced coregistration. Eighteen pairs of landmarks along the perimeter of the brain specimens 
were manually placed on the MR image and grayscale H&E image. The transformation matrix of the two-
dimensional thin plate spline (TPS) registration was computed in MIPAV (version 10.0.0) and applied to 
warp the H&E image to the orientation of the MR image. After co-registration, the pathologist defined tumor 
histology regions on H&E images. These were then successfully transferred to the corresponding MR image.
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the regions of interest (ROI) with pathologist-identified tumor histology on the H&E images can be transferred 
to DBSI for further analysis (Fig. 2).
Deep neural network (DNN) model development and optimization. Our complete dataset con-
sisted of 99,388 imaging voxels from 45 specimens obtained from 9 patients. The collected voxels were split into 
training, validation, and test datasets with an 8:1:1 ratio, respectively. Imaging voxels from test datasets were 
separated and distinct from the ones that were used in the training and validation steps. Validation set was 
employed to fine tune the model hyper-parameters. To balance data from groups of different tumor histologic 
components, a synthetic minority oversampling technique (SMOTE)18 was applied to over-sample the minority 
group by introducing synthetic feature samples. This data balancing approach has been demonstrated to be ben-
eficial for avoiding over-fitting and improving model  generalization18,19. Data balancing were only applied to the 
training dataset, while the validation and test dataset was kept unchanged. The diffusion metrics assessed with 
our DNN modeling included 10 diffusion metrics provided from DBSI. Specifically, DBSI metrics include mean 
apparent diffusion coefficient (ADC), mean FA, fiber fraction, fiber fractional anisotropy (FA), fiber axial dif-
fusivity (AD), fiber radial diffusivity (RD), restricted isotropic diffusion fraction (restricted fraction), restricted 
isotropic diffusivity, hindered isotropic diffusion fraction (hindered fraction), hindered isotropic diffusivity, free 
isotropic diffusion fraction (free fraction), free isotropic diffusivity.
A supervised deep neural network (DNN) was adopted to detect and classify tumor histologic components 
by referencing the H&E findings. The DNN model was developed using TensorFlow 2.0 framework in Python 
3.6.820. In general, the DNN model was equipped with ten fully connected hidden layers. Batch normalization 
layer with a mini-batch size of 200 was used before feeding data to the next hidden layer to improve model 
optimization and prevent overfitting. Exponential linear  units21 were adopted to activate specific functions in 
each hidden layer. The final layer was a fully connected softmax layer that generated a likelihood distribution of 
six output classes. We used Adam optimizer with the default parameters of β1 = 0.9, β2 = 0.999 and mini-batch 
size of 200. The learning rate was manually tuned to achieve the fastest convergence. We chose cross-entropy 
as the loss function and trained the model to minimize the error rate on the validation dataset. Overall, hyper-
parameters for the DNN architecture and optimization algorithm were chosen through a combination of grid 
search and manual tuning.
Statistical analysis. Statistical differences in diffusion metrics between the tumor histology groups were 
evaluated by the Mann–Whitney U test. The results were presented as mean ± standard deviation. A p < 0.05 
was considered statistically significant. In multi-class classification, confusion matrices were calculated and 
used to illustrate the specific examples of tumor histologic components where the model prediction agrees with 
the pathologists’ diagnoses. We also used one-versus-rest strategy to perform receiver operating characteristics 
(ROC) analysis. Area under curve (AUC) was calculated to assess model discrimination of each tumor histo-
logical component. Sensitivity and specificity values were calculated using Youden  Index22. The precision-recall 
curve and  F1-scores were also calculated to provides complementary information to the ROC curves.  F1-score 
(ranges from 0 to 1) favors models that maximize both precision and recall simultaneously, which is especially 
helpful to address the insensitivity of AUC on class imbalance. The 95% confidence interval values were calcu-
lated using the percentile bootstrap method with 10,000 independent  experiments23. All the statistical metrics 
and curves were calculated using the  SciPy24 and Scikit-learn25 packages with Python version 3.6.
Results
A brief description of tumor specimens examined. Postmortem brain tumor specimens examined 
were from 9 pediatric brain tumor patients, aged from 4 to 17 years old at the time of initial diagnosis. The mean 
age was 10.8 ± 3.7 years old. The patients’ age at autopsy ranged from 7 to 18, with a mean of 13.1 ± 3.7 years. Four 
tumors were located in the brainstem, two in the thalami, one in the right cerebral cortex, and one at the cerebel-
lopontine angle. These were confirmed to be diffuse midline gliomas with H3K27M mutation by immunohisto-
chemistry (n = 4), glioblastoma (n = 3), and embryonal tumor with multilayered rosettes with LIN28A protein 
overexpression (medulloepithelioma phenotype, NEC; n = 1). One patient with neurofibromatosis 1 (NF1) had 
three different tumors at three distinct time points; these were an optic pathway glioma (pilocytic astrocytoma), 
a diffuse astrocytoma, WHO grade II involving the right parieto-temporal lobe, and a CNS embryonal tumor 
involving the right temporal lobe. All details are summarized in Table 1.
Relating MRI metrics to tumor pathologies. Figures 1 and 3 show a representative case from a 16-year-
old brain tumor patient with embryonal neoplasm (WHO Grade IV). Clinical gadolinium (Gd)-enhanced 
T1-weighted imaging of this patient several weeks prior to death revealed a new lesion in the right temporal 
lobe of the brain (Fig. 1a, square). At autopsy, the brain was removed and immediately suspended in formalin 
for fixation (Fig. 1b). Coronal slices exhibited a large hemorrhagic and necrotic tumor mass with its epicenter in 
the right thalamus (Fig. 1c). Tissue blocks were obtained from this region (Fig. 1d) for ex vivo imaging (Fig. 2). 
Of note, this patient had two other known tumors, one in his optic pathway (WHO grade I) and another diffuse 
astrocytoma (WHO grade II) in right posterior temporo-parietal lobe. The boundaries of latter were however 
relatively indistinct from the high-grade hemorrhagic and necrotic embryonal neoplasm (WHO grade IV) by 
gross examination alone.
A densely cellular tumor region and white matter (WM) were indistinguishable in both T1-weighted image 
(T1WI) and T2-weighted image (T2WI) (Fig. 3). Hemorrhage appeared hypointense compared to other regions in 
T1WI and T2WI (Fig. 3). White matter and the hemorrhagic region appeared hyperintense in diffusion-weighted 
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Table 1.  Patient information.
Patient ID Age at diagnosis Age at post-mortem Gender Location Histologic diagnosis Molecular alterations
WU-1 9 9 F Thalamus Diffuse midline glioma, WHO grade IV
H3K 27M mutant (by immunohis-
tochemistry
WU-2 11 14 M Left temporal lobe Glioblastoma, IDH wildtype, WHO grade IV
Tumor progressed from IDH 
wildtype anaplastic astrocytoma. 
Next generation sequencing 
showed CREBBP G1479 alteration
WU-3 11 12 F Right parietal-occipital lobe Diffuse midline glioma, WHO grade IV
H3K 27M (by immunohistochem-
istry
WU-4 7 16 M
1. Right temporal lobe
CNS embryonal tumor with 
anaplastic features, WHO grade 
IV (2013)
Background of NF1 with three 
tumors at different time points
2. Right posterior temporoparietal 
lobe
Diffuse astrocytoma, WHO grade 
II (2006)
18 non-synonymous variants 
were identified by next generation 
sequencing TP53, p.R213Dfs*34, 
TP53 and p.T211I
3. Optic pathway Pilocytic astrocytoma, WHO grade I (not sampled until post-mortem) MAP2K2,p.I369V
WU-5 10 10 M Pons Diffuse midline glioma, WHO grade IV
H3K 27M mutant (by immunohis-
tochemistry
WU-6 13 14 M Pons Diffuse midline glioma, WHO grade IV
H3K 27M mutant (by immunohis-
tochemistry
WU-7 4 7 F Right cerebellopontine angle
Embryonal tumor with multilay-
ered rosettes, medulloepithelioma 
phenotype, WHO grade IV, NEC
FISH could not demonstrate 
C19MC alteration but multifocal 
LIN28A protein expression was 
seen by immunohistochemistry
WU-8 17 18 M
Right cerebral hemisphere 
(extensive involvement left side, 
brainstem and cerebellum)
Glioblastoma, IDH wildtype, 
WHO grade IV
Loss of 10q (PTEN) and monosomy 
10 (by FISH); no EGFR amplifica-
tion or polysomy of chromosome 7
WU-9 15 18 F
Epicenter in brainstem, right 
thalamus, right basal ganglia, and 
cerebellum
Glioblastoma, IDH wildtype, 
WHO grade IV
H3K 27M negative (by immunohis-
tochemistry)
Figure 3.  A representative tissue block was imaged with ex vivo MRI, followed by histologic processing and 
evaluation. (a) H&E image of a sectioned specimen after ex vivo MRI with regions of white matter, densely 
cellular tumor and hemorrhage outlined for assessing the efficacy of metrics derived by multi-parametric MRI 
and DBSI. The expanded region of densely cellular tumor features characteristically increased cellularity. Scale 
bar measures 50 um. (b) T1W and T2W MRI did not distinguish densely cellular tumor region from white 
matter or hemorrhage. Most strikingly, diffusely cellular tumor region exhibited lower DWI and higher ADC 
countering the conventional wisdom that higher tumor cellularity is associated with restricted diffusion. WM 
white matter, DC tumor densely cellular tumor.
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image (DWI) and hypointense in ADC map comparing with the densely cellular tumor regions. Densely cellular 
tumor appeared to associate with high restricted fraction.
DBSI derived diffusion metrics reflected tumor pathologies. After MR images were co-registered 
with H&E images, image-voxels from segmentations of the five different tumor pathologies were subsequently 
obtained and plotted for group comparison (Fig. 4). The ADC of densely cellular tumor (0.43 ± 0.17 µm2/ms) 
was 115% higher (p < 0.05) than then normal white matter and 42% higher (p < 0.05) than the infiltrative edge 
(0.30 ± 0.15 µm2/ms). Additionally, the densely cellular tumor was 17% lower (p < 0.05) than the less densely cel-
lular tumor (0.52 ± 0.26 µm2/ms), and 37% lower (p < 0.05) than the necrosis (0.68 ± 0.37 µm2/ms) (Fig. 4a). DTI 
fractional anisotropy (FA) value of the tumor infiltrative edge was similar to that of white matter (0.23 ± 0.14 
vs. 0.24 ± 0.11) (Fig. 4b). The comparison of isotropic ADC values derived by DBSI among tumor pathologies 
revealed a similar trend as seen in mean ADC and were consistently higher than mean ADC (Fig. 4c). For the 
highly restricted fraction, WM exhibited much higher values than other pathologies. Densely and less densely 
cellular tumors exhibited the least highly restricted fraction values among all histologic features (Fig. 4d). For 
the restricted fraction, densely cellular tumor (0.35 ± 0.10) showed 35%, 21%, 21% and 59% higher (all p < 0.05) 
values than normal WM (0.26 ± 0.11), less densely cellular tumor (0.29 ± 0.09), infiltrative edges (0.29 ± 0.12) and 
necrosis (0.22 ± 0.15), respectively. This result correlated well with the expected cellularity decrease from densely 
cellular, less densely cellular tumor regions to necrotic tissue (Fig. 4e). As expected, necrosis was characterized 
by higher hindered fraction (0.42 ± 0.21) and free fraction values (0.11 ± 0.12) than any of the other histologic 
features. In the anisotropic fraction, normal WM (0.38 ± 0.12) and infiltrative edge (0.36 ± 0.17) had similar val-
ues; this anisotropic component was much higher than other histologic components.
Classifications of tumor histologic components. It was clear that DBSI is more specific to tumor 
pathologies than conventional MRI metrics. To alleviate overlap between DBSI-derived metrics and tumor 
pathologies, we sought to classify tumor pathologies using DHI, by combining DBSI-derived structural metrics 
with DNN algorithm. We first performed a multi-class classification of normal WM, densely cellular tumor, less 
densely cellular tumor, infiltrative edge, necrosis, and hemorrhage regions containing a total of 143,100 image 
voxels to train the DHI model after oversampling for data balancing. Representative H&E images correspond-
ing to one MRI voxel revealed distinct histologic features (Fig. 5a). For the independent test set (n = 9939), we 
achieved an overall accuracy of 85.8%. Confusion matrix analysis indicated strong concordance between DHI 
predictions and the neuropathologist-identified pathological features (Fig. 5b). DHI accurately predicted nor-
mal WM, densely cellular tumor, less densely cellular tumor, infiltrative edge, necrosis, and hemorrhage, with 
true positive rates of 91.6%, 80.6%, 90.8%, 80.2%, 81.4% and 86.7%, respectively.
To test DHI’s ability to distinguish each individual tumor pathology, we adopted a one-versus-rest strategy to 
perform receiver operating characteristic (ROC) and precision-recall analysis (Fig. 6). The ROC curves indicated 
high area under curve (AUC) values in the differentiation of all six different histologic components (Fig. 6a–f). 
We calculated 95% confidence intervals (CI) of AUCs using the percentile bootstrap method with 10,000 itera-
tions. The AUC values (95% CI) were 0.984 (0.982–0.986), 0.960 (0.956–0.963), 0.991 (0.990–0.993), 0.950 
(0.944–0.956), 0.977 (0.973–0.981) and 0.976 (0.972–0.979) for normal WM, densely cellular tumor, less densely 
cellular tumor, infiltrative edge, necrosis and hemorrhage, respectively (Table 2). We also calculated sensitiv-
ity and specificity for each class under the Youden Index. All the sensitivity values were higher than 91% with 
specificity values higher than 85% (Table 2). We also calculated precision-recall curves and  F1-scores to provide 
complementary information to address ROC analyses’ insensitivity to class imbalance and the possible overes-
timation of model performance. The precision-recall curves performed inferiorly on tumor infiltration (Fig. 6d, 
AUC 0.747) and necrosis (Fig. 6e, AUC 0.851) when compared to other tumor histologic regions. Similarly, 
the  F1-scores of the infiltrative edge (0.698) and necrosis (0.799) were worse than those of normal white matter 
(0.918), densely cellular tumor (0.850), less densely cellular tumor (0.911), and hemorrhage (0.848) (Table 2).
Discussion
Pediatric brain tumors are the leading cause of cancer-related death in children. Current curative approaches in 
management rely, in most cases, on complete surgical resection, followed by irradiation and  chemotherapy4,26. 
Histologic assessment of tumor cellularity, infiltration and necrosis is critical in the diagnosis and grading, as 
well as subsequent clinical decision-making for patient management and follow-up27. The current clinical gold 
standard, i.e. histologic examination, requires stereotactic biopsy or surgical  resection28, which carries potential 
risks including infections, seizures, stroke, coma, as well as brain swelling or  bleeding29. Sometimes inconclusive 
pathological findings result from inadequate sampling, necessitating repeat biopsy, with all its attendant  risks30. 
A noninvasive neuroimaging approach to facilitate diagnosis or guide surgical planning will ensure better treat-
ment response assessment, ultimately improving patient  care31.
While MRI remains the most common clinical imaging technique for evaluating CNS  tumors5, conventional 
MRI sequences such as T1WI and T2WI correlated poorly with pathologies of high-grade brain tumors. For 
example, hyperintense regions in T2W and FLAIR images surrounding the Gadolinium (Gd)-enhancing lesion 
cannot distinguish between infiltrative tumor, vasogenic edema, or immune  cell32. Gd-enhancement in T1WI 
also could occur due to either tumor progression or radiation  necrosis33. Furthermore, conventional T1W and 
T2W image contrasts vary from scan to scan and are not quantitative, as they depend not only on the MR char-
acteristics of brain tissue, but also on the scanner models, magnet strength, and pulse sequences.
To address the limitations of conventional MRI bridging the gap between histology and MRI for pediatric 
brain tumor diagnoses, we developed a novel image processing technique, i.e., DHI, taking advantage of previ-
ously developed DBSI and DNN algorithm. DBSI provides a simple tensor expression to visualize morphological 
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Figure 4.  Group analysis on different tumor histologic components on representative diffusion metrics including (a) ADC, (b) DTI 
FA, (c) DBSI isotropic ADC, (d) highly restricted fraction, (e) restricted fraction, (f) hindered fraction, (g) free fraction, and (h) fiber 
fraction. Particularly, normal WM and the infiltrative edge showed higher fiber fraction and DTI-FA than the other tumor histologies. 
DC tumor and LDC tumor showed higher restricted fraction values than other histologies. Necrosis showed higher ADC, hindered 
fraction and free fraction values as well as lower restricted fraction, fiber fraction and DTI-FA compared to the other histologies. These 
findings were collectively consistent with DBSI’s modelling for malignant brain tumor. ADC, µm2/ms. Normal WM normal white matter, 
DC tumor densely cellular tumor, LDC tumor less densely cellular tumor.
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features resulting from both tumor and non-tumor elements of the brain that are indistinguishable by conven-
tional MRI. In our previous studies, we demonstrated how DBSI-derived restricted fraction positively correlated 
with adult GBM tumor cellularity identified by H&E  staining17. In this study, we demonstrated that the hyper-
intense restricted fraction regions also accurately identify densely cellular tumor areas (Fig. 2). Group analysis 
across multiple samples with various tumor types also indicated densely cellular tumor had higher restricted 
fraction values than either normal WM, less densely cellular tumor, infiltrative edges or necrosis. From the areas 
of necrosis, infiltrating edge, less densely cellular tumor, and densely cellular tumor, we observed a trend towards 
a gradual increase in restricted fraction values across these four types of histological areas. Thus, the restricted 
fraction could serve as an appropriate biomarker to assess tumor cellularity in high-grade pediatric brain tumors.
In addition, necrosis exhibited higher values in hindered diffusion fraction and free diffusion fraction than 
all other histologic components, indicating that these two diffusion metrics are strongly associated with tumor 
necrosis. Furthermore, our results showed comparable ADC, FA, restricted fraction, and fiber fraction values 
between the infiltrative edge and normal WM, suggesting that these diffusion metrics lack adequate specificity 
to distinguish between infiltrating tumor cellularity and white matter. Note that infiltrative edges showed higher 
isotropic ADC and hindered fraction values than do normal WM, potentially pointing to how tumor infiltration 
displaces normal  parenchyma34, destructs of white matter  tracts35, and/or forming vasogenic edema to disrupt 
blood brain  barrier36.
In this study, we demonstrated that DHI, i.e., DBSI-derived metrics as the input classifiers for DNN, differ-
entiates 6 major types of tumor pathologies with an overall accuracy of 85.8%. In detecting and distinguishing 
individual tumor histology, ROC analysis of DHI models calculated the AUC, sensitivity, and specificity values of 
all selected tumor pathologies to be higher than 0.94, 88% and 86%, respectively. In the precision-recall analysis, 
Figure 5.  (a) Representative H&E images of normal white matter, densely cellular tumor, less densely cellular 
tumor, infiltrative edge, necrosis and hemorrhage, respectively. (b) Independent test dataset confusion matrix 
for the predictions of DHI versus gold standard, i.e. histologic examination (n = 9939). Rows contain tumor 
histologic classifications identified by a neuropathologist, and columns represent tumor histologic classifications 
as predicted by DHI. Scale bar measures 100 μm. Normal WM normal white matter, DC tumor densely cellular 
tumor, LDC tumor less densely cellular tumor.
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the prediction of infiltrative edge was relatively low for AUC (0.747) and in  F1-score (0.698), likely due to the 
highly variable degrees of infiltration or inherent cellularity differences among brain tumors and infiltrated brain 
regions. For example, infiltrative edges with mild to intermediate tumor cellularity could be falsely predicted to 
be normal WM. Similar phenomenon was observed from the results of confusion matrix (Fig. 5b).
Figure 6.  Receiver operating characteristics (ROC) curves and precision-recall (PR) curves calculated 
using one-vs-rest strategy for 6 different tumor histological components including (a) normal white matter, 
(b) densely cellular tumor, (c) less densely cellular tumor, (d) tumor infiltrative edge, (e) tumor necrosis 
and (f) hemorrhage. All 6 ROC curves showed high areas under curve (AUC), indicating strong sensitivity 
and specificity in detecting these tumor histologic components. Tumor infiltrative edge did not perform as 
well as other histologic components in precision-recall analysis, indicating that tumor infiltration could be 
overestimated by the model. Normal WM normal white matter, DC tumor densely cellular tumor, LDC tumor 
less densely cellular tumor.
Table 2.  Diagnostic performances of DHI in classifying different tumor histologies. The 95% confidence 
interval (CI) values were calculated using percentile bootstrap method with 10,000 independent experiments. 
CI confidence interval, Normal WM normal white matter, DC tumor densely cellular tumor, LDC tumor less 
densely cellular tumor.
Tumor histology Sensitivity (%) Specificity (%) AUC (95% CI) F1-score
Normal WM 94.1 (92.8–97.4) 93.3 (89.6–94.3) 0.984 (0.982–0.986) 0.918
DC tumor 88.9 (87.2–90.6) 89.8 (88.2–91.3) 0.960 (0.956–0.963) 0.850
LDC tumor 97.3 (96.3–98.1) 93.8 (92.9–94.7) 0.991 (0.990–0.993) 0.911
Infiltrative edge 90.8 (87.6– 94.2) 86.7 (83.2–89.1) 0.950 (0.944–0.956) 0.698
Necrosis 94.5 (92.4–96.8) 90.0 (87.7–91.6) 0.977 (0.973–0.981) 0.799
Hemorrhage 91.5 (88.8–94.4) 92.2 (89.2–94.5) 0.976 (0.972–0.979) 0.848
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In contrast to previous studies, we adopted a voxel-wise analysis through precise co-registration between 
histology and MR images, to bridge MRI and histology. Application of this approach accurately detected distinct 
regions within pediatric brain tumors that were histologically  heterogeneous37,38. Image voxels within a region 
of interest from a specimen could vary differently from each other, reflecting histological heterogeneity. Since 
DBSI models diffusion-weighted MRI signals independent of neighboring image  voxels10, each image voxel 
has its own DBSI metric profiles. Thus, DBSI provides a unique opportunity to assess the heterogeneous tumor 
pathology-associated structural changes within individual image voxels. DBSI-derived structural metrics are 
thus ideal to serve as the unique input classifiers for the DNN algorithm. Patient-wise analysis has been typically 
studied by correlating image metrics with clinical scores or survival rates. There have been attempts to correlate 
MRI signal with tumor histopathology using stereotactic  biopsy39,40. However, the analyses have been hindered 
by spatial misalignment between MRI-defined lesions and biopsy location, in addition to the high histological 
heterogeneity of high-grade pediatric brain tumors.
Although the relatively small number of subjects (n = 9) limited the broad applicability of the results, we per-
formed voxel-wise analyses (matching the DBSI voxel-based modeling characteristics) on a total of 99,388 image 
voxels from 45 brain specimens covering different areas of the brain alleviating the limitation on sample size 
while providing a proof-of-concept demonstration of DHI. The unbalanced data distribution amongst different 
tumor histologic components imposed another limit since the imbalance could compromise the performance of 
a DNN model. We have addressed the concern by employing an oversampling approach to balance the training 
data and adopted precision-recall analyses to provide complement ROC analyses.
In conclusion, we have demonstrated that DHI can accurately characterize and classify multiple histologies 
in fixed postmortem specimens of pediatric high-grade brain tumors. While precise prediction of infiltrative 
edges was suboptimal, the collective findings are encouraging. The efficacy of DHI classification of pediatric brain 
tumor pathologies still requires in vivo application with image-guided stereotactic biopsy validation.
Data availability
The datasets generated during and/or analyzed during the current study are not publicly available due to sensitive 
patient information but are available from the corresponding author on reasonable request.
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